PDCD1 and cancer: BCA patients who were positive for PD1 had a 3.220-fold higher risk of death (95% CI, 1.707–6.075) and a 2.095-fold higher risk of death or cancer relapse (95% CI: 1.292–3.395) compared to patients who were negative for PD1 (Table 2).